ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.
Industry, Sector and Symbol
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-20-83362900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£69.74 million
Profitability
Miscellaneous
Employees207
Next Earnings Date6/27/2019 (Estimated)
OptionableNot Optionable
Eco Animal Health Group (LON:EAH) Frequently Asked Questions
What is Eco Animal Health Group's stock symbol?
Eco Animal Health Group trades on the London Stock Exchange (LON) under the ticker symbol "EAH."
How often does Eco Animal Health Group pay dividends? What is the dividend yield for Eco Animal Health Group?
Eco Animal Health Group announced a dividend on Monday, December 10th. Shareholders of record on Thursday, December 20th will be paid a dividend of GBX 3.50 per share on Wednesday, January 9th. This represents a dividend yield of 0.86%. The ex-dividend date is Thursday, December 20th. The official announcement can be viewed at this link. View Eco Animal Health Group's Dividend History.
When is Eco Animal Health Group's next earnings date?
What price target have analysts set for EAH?
2 brokerages have issued 1-year price targets for Eco Animal Health Group's shares. Their forecasts range from GBX 725 to GBX 725. On average, they anticipate Eco Animal Health Group's share price to reach GBX 725 in the next year. This suggests a possible upside of 94.4% from the stock's current price. View Analyst Price Targets for Eco Animal Health Group.
What is the consensus analysts' recommendation for Eco Animal Health Group?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eco Animal Health Group in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eco Animal Health Group.
Has Eco Animal Health Group been receiving favorable news coverage?
Press coverage about EAH stock has trended positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Eco Animal Health Group earned a coverage optimism score of 2.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days.
Who are some of Eco Animal Health Group's key competitors?
Some companies that are related to Eco Animal Health Group include Mayne Pharma Group (MYX), Vectura Group (VEC), Medical Developments International (MVP), BEXIMCO PHARMAC/S GDR REGS (BXP), Opthea (OPT), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY), Futura Medical (FUM), Vita Life Sciences (VLS), Cathay International (CTI), Patrys (PAB), Recce Pharmaceuticals (RCE), Avivagen (VIV) and Antisense Therapeutics (ANP).
What other stocks do shareholders of Eco Animal Health Group own?
Who are Eco Animal Health Group's key executives?
Eco Animal Health Group's management team includes the folowing people:
- Mr. Marc Denham Loomes, CEO & Exec. Director (Age 58)
- Mr. Kevin Anthony Stockdale BSc, ACA, Fin. Director & Exec. Director (Age 54)
- Mr. Brett Clemo BA (Hons), Exec. Director (Age 57)
- Ms. Julia Trouse, Sec. & Exec. Director (Age 53)
How do I buy shares of Eco Animal Health Group?
Shares of EAH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Eco Animal Health Group's stock price today?
One share of EAH stock can currently be purchased for approximately GBX 373.
How big of a company is Eco Animal Health Group?
Eco Animal Health Group has a market capitalization of £251.56 million and generates £69.74 million in revenue each year. Eco Animal Health Group employs 207 workers across the globe.
What is Eco Animal Health Group's official website?
How can I contact Eco Animal Health Group?
Eco Animal Health Group's mailing address is 78 Coombe Road, NEW MALDEN, KT3 4QS, United Kingdom. The company can be reached via phone at +44-20-83362900.
MarketBeat Community Rating for Eco Animal Health Group (LON EAH)
MarketBeat's community ratings are surveys of what our community members think about Eco Animal Health Group and other stocks. Vote "Outperform" if you believe EAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EAH will underperform the S&P 500 over the long term. You may vote once every thirty days.
